Timothy Carll to Anilides
This is a "connection" page, showing publications Timothy Carll has written about Anilides.
Connection Strength
0.042
-
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201). Clin Cancer Res. 2020 02 15; 26(4):804-811.
Score: 0.042